MX9201058A - Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene. - Google Patents
Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.Info
- Publication number
- MX9201058A MX9201058A MX9201058A MX9201058A MX9201058A MX 9201058 A MX9201058 A MX 9201058A MX 9201058 A MX9201058 A MX 9201058A MX 9201058 A MX9201058 A MX 9201058A MX 9201058 A MX9201058 A MX 9201058A
- Authority
- MX
- Mexico
- Prior art keywords
- supreparation
- cetal
- cyclical
- derivatives
- procedure
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical class C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919105152A GB9105152D0 (en) | 1991-03-12 | 1991-03-12 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9201058A true MX9201058A (es) | 1992-09-01 |
Family
ID=10691384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9201058A MX9201058A (es) | 1991-03-12 | 1992-03-11 | Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0503520A1 (es) |
| JP (1) | JPH06505719A (es) |
| AU (1) | AU1352792A (es) |
| CA (1) | CA2106072A1 (es) |
| GB (1) | GB9105152D0 (es) |
| IE (1) | IE920782A1 (es) |
| MX (1) | MX9201058A (es) |
| WO (1) | WO1992016530A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69214127T2 (de) * | 1991-01-09 | 1997-02-13 | Glaxo Group Ltd | Überbrückte, cyclische ketale |
| US5256689A (en) * | 1991-05-10 | 1993-10-26 | Merck & Co., Inc. | Cholesterol lowering compounds |
| US5506262A (en) * | 1991-05-10 | 1996-04-09 | Merck & Co., Inc. | Cholesterol lowering compounds |
| US5294627A (en) * | 1992-08-27 | 1994-03-15 | Merck & Co., Inc. | Directed biosynthesis of biologically active compounds |
| US5252471A (en) * | 1992-03-09 | 1993-10-12 | Merck & Co., Inc. | Directed biosynthesis of cholesterol lowering compounds |
| US5302604A (en) * | 1992-03-09 | 1994-04-12 | Merck & Co., Inc. | Cholesterol lowering compounds produced by directed biosynthesis |
| US5258401A (en) * | 1992-07-10 | 1993-11-02 | Merck & Co., Inc. | Cholesterol lowering compounds |
| US5369125A (en) * | 1992-07-17 | 1994-11-29 | Merck & Co., Inc. | Cholesterol-lowering agents |
| US5270332A (en) * | 1992-08-21 | 1993-12-14 | Merck & Co., Inc. | Cholesteral lowering agents |
| US5326783A (en) * | 1992-08-25 | 1994-07-05 | Merck & Co., Inc. | Cholesterol lowering compounds |
| US5278320A (en) * | 1992-09-11 | 1994-01-11 | Merck & Co., Inc. | Cholesterol lowering compounds produced by directed biosynthesis |
| US5332728A (en) * | 1992-11-23 | 1994-07-26 | Bristol-Myers Squibb Company | Method for treating a fungal infection |
| US5447717A (en) * | 1993-02-25 | 1995-09-05 | Merck & Co., Inc. | Cholesterol-lowering agents |
| US5712261A (en) * | 1993-10-04 | 1998-01-27 | Magnin; David R. | Method for preventing or treating hypertriglyceridemia |
| US5783593A (en) * | 1993-11-04 | 1998-07-21 | Abbott Laboratories | Inhibitors of squalene synthetase and protein farnesyltransferase |
| US5631401A (en) * | 1994-02-09 | 1997-05-20 | Abbott Laboratories | Inhibitors of protein farnesyltransferase and squalene synthase |
| US5430055A (en) * | 1994-04-08 | 1995-07-04 | Pfizer Inc. | Inhibitor of squalene synthase |
| WO2002067895A2 (en) * | 2000-11-16 | 2002-09-06 | Durect Corporation | Implant dosage form and use thereof for the delivery of a cholesterol lowering agent |
| EP1380306B1 (en) | 2001-03-30 | 2009-03-04 | Toray Industries, Inc. | Remedies for restless leg syndrome |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837205A (en) * | 1986-09-02 | 1989-06-06 | Merck & Co., Inc. | Prodrugs of antihypercholesterolemic compounds |
| US4880798A (en) * | 1986-11-25 | 1989-11-14 | Mochida Pharmaceutical Co., Ltd. | Cephalosporin derivatives |
| IL97535A0 (en) * | 1990-03-21 | 1992-06-21 | Merck & Co Inc | Squalene synthetase inhibitor dioxabicyclo(1,2,3)octanes,their production and pharmaceutical compositions containing them |
-
1991
- 1991-03-12 GB GB919105152A patent/GB9105152D0/en active Pending
-
1992
- 1992-03-07 AU AU13527/92A patent/AU1352792A/en not_active Abandoned
- 1992-03-07 JP JP50550092A patent/JPH06505719A/ja active Pending
- 1992-03-07 EP EP92103956A patent/EP0503520A1/en not_active Withdrawn
- 1992-03-07 CA CA002106072A patent/CA2106072A1/en not_active Abandoned
- 1992-03-07 WO PCT/EP1992/000509 patent/WO1992016530A1/en not_active Ceased
- 1992-03-11 MX MX9201058A patent/MX9201058A/es unknown
- 1992-03-11 IE IE078292A patent/IE920782A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU1352792A (en) | 1992-10-21 |
| IE920782A1 (en) | 1992-09-23 |
| CA2106072A1 (en) | 1992-09-13 |
| GB9105152D0 (en) | 1991-04-24 |
| JPH06505719A (ja) | 1994-06-30 |
| WO1992016530A1 (en) | 1992-10-01 |
| EP0503520A1 (en) | 1992-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9202289A (es) | Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9206503A (es) | Nuevos derivados de lupano, proceso para su preparacion y composicion farmaceutica que los contiene. | |
| MX9204140A (es) | Nuevos derivados de analogos de taxol, procedimiento para su preparacion y composicion farmaceutica que los contienen. | |
| MX9205280A (es) | Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9202982A (es) | Derivados de los acidos quinolon - y naftiridon - carboxilicos, procedimiento para su obtencion y medicamentos que los contienen. | |
| MX9202619A (es) | Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene. | |
| MX9206306A (es) | Peptidos, procedimiento para su produccion y composicion farmaceutica que los contiene. | |
| MX9202748A (es) | Compuesto de arileter, proceso para su obtencion y composicion farmaceutica que los contiene. | |
| MX9201058A (es) | Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene. | |
| MX9200324A (es) | Nuevos esteroides, procedimiento para su preparacinuevos esteroides, procedimiento para su preparacion y composicion farmaceutica que los contiene. on y composicion farmaceutica que los contiene. | |
| MX9204354A (es) | Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen. | |
| MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
| MX9102501A (es) | Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion. | |
| MX9200180A (es) | DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE. | |
| MX9204844A (es) | Derivados de benzodioxano, procedimiento para su preparacion composiciones farmaceuticas que los contienen. | |
| MX9201295A (es) | Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contienen. | |
| MX9102500A (es) | Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9202152A (es) | Derivados del indol, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9102580A (es) | Nuevas benzodiacepinonas, procedimiento para su preparacion y composicion farmaceutica que las contiene. | |
| MX9204563A (es) | Nuevos derivados de la (2-alquil-3-piridil)-metilpiperazina y composicion farmaceutica que los comprende. | |
| MX9201847A (es) | Derivados heterociclicos de antiserotoninas, procedimiento para su preparacion y medicamentos que los contienen. | |
| MX9202300A (es) | Derivados de benzofurano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9204395A (es) | Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| MX9201848A (es) | Antiserotoninas, procedimiento para su preparacion y medicamentos que las contienen. | |
| MX9102499A (es) | Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene. |